| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |